1, the meaning of precision medicine
Precision medicine is a new type of medical concept and medical model developed in the context of the rapid progress of gene sequencing technology and the cross-application of bioinformatics and big data science. Precision medicine is an emerging approach to disease prevention and treatment that takes into account differences in individual genes, the environment, and lifestyle habits.
Precision medicine is an emerging approach to disease prevention and treatment that takes into account differences in individual genes, the environment, and lifestyle habits.
Precision medicine is a new type of medical concept and medical model based on individualized medical treatment and developed with the rapid progress of genome sequencing technology and the cross-application of bioinformatics and big data science.
The essence of precision medicine is to analyze, identify, validate and apply biomarkers to large samples of people and specific disease types through genome, proteome and other genomics technologies as well as cutting-edge medical technologies, so as to accurately search for the causes of diseases and the targets of treatments, and accurately classify the different states and processes of a disease, and ultimately achieve the goal of personalized and precise treatments for diseases and specific patients, and improve the diagnosis and treatment of diseases and prevention of diseases. The aim is to realize personalized and precise treatment for diseases and specific patients, and to improve the effectiveness of diagnosis, treatment and prevention of diseases.
2, the future development trend of precision medicine
In 2017, China's precision medicine field occurred 101 investment cases, the investment amount of 12.236 billion yuan, of which the number of cases of investment over 100 million yuan 31 cases, the investment of more than 100 million cases involving an amount of 10.273 billion yuan, accounting for 84% of the total financing. In addition, WuXi Biologicals, Zaidin Pharmaceuticals, Key Egg Bio, UW Genetics, Turbogene Bio, Gemdale Medical, Kemper Bio, and Ed Biologicals, eight precision medicine companies IPO listed, with a total IPO amount of 7.363 billion yuan. From the point of view of subdivided technology fields, gene sequencing, antibody drugs, etc. are the key areas of capital layout, these two fields total **** completed 75 financing, involving an amount of 10.77 billion yuan. Among them, the highest average financing amount is antibody drugs, with a single financing amount of 223 million yuan.
With the development of large-scale biological sample databases, powerful histology and medical technology, computing tools and big data, the status of precision medicine has been significantly enhanced. As a new type of treatment based on each individual's genes and health differences to develop personalized treatment and prevention programs, precision medicine may be able to lead a new era of medicine.